User talk:Oeryc
Add topic| This is Oeryc's talk page, where you can send them messages and comments. |
|
Your submission at Articles for creation: Di-β-phenylisopropylamine has been accepted
[edit]
Congratulations, and thank you for helping expand the scope of Wikipedia! We hope you will continue making quality contributions. Feel free to further improve your accepted article.
Future articles
- Since you have made at least 10 edits over more than four days, you can now create articles yourself without submitting a draft for review. However, you may continue submitting drafts to Articles for creation if you prefer.
- Once you have made at least 10 edits and had an account for at least four days, you will have the option to create articles yourself without posting a request to Articles for creation.
Next steps
- Find other Wikipedia articles related to your topic and add links pointing to the new article. This helps readers find it.
- Group the article with similar subjects by adding relevant categories.
- You may consider nominating a fact from the article within the next 7 days to appear on the Main Page's Did you know section.
- Wikipedia is a work in progress. You can continue to expand and improve the new article.
- The new article will become eligible to be indexed on search engines once patrolled or after 90 days; search engines may take time to reflect this.
- For friendly peer support regarding editing, sourcing, or policies, visit the Teahouse, a question and answer hub for new editors.
Thanks again, and happy editing!
Sulfurboy (talk) 17:33, 14 August 2026 (UTC)Your submission at Articles for creation: Thymus quinquecostatus (August 16)
[edit]
- We can only accept text if it is explicitly released under a compatible free license or is in the public domain.
- If the text is not freely licensed, you must rewrite or summarize it entirely in your own words. Changing a few words is still considered a copyright violation.
- If you own the text you cannot paste it here unless you formally release it via our release process.
- Draft:Thymus quinquecostatus may be deleted at any time unless the copied text is removed. Copyrighted work cannot be allowed to remain on Wikipedia.
- If you need any assistance, you can ask for help at the Articles for creation help desk or on the reviewer's talk page..
Scam warning
- If anyone asks you for money or payment to publish, protect, or restore a Wikipedia article or draft, it is a scam. Learn about scams on Wikipedia.
Hello, Oeryc!
Having a draft declined at Articles for creation can be disappointing, but don't be discouraged, it's common when creating your first article. Need help?
|
Your submission at Articles for creation: Thymus quinquecostatus has been accepted
[edit]
Congratulations, and thank you for helping expand the scope of Wikipedia! We hope you will continue making quality contributions. Feel free to further improve your accepted article.
Future articles
- Since you have made at least 10 edits over more than four days, you can now create articles yourself without submitting a draft for review. However, you may continue submitting drafts to Articles for creation if you prefer.
- Once you have made at least 10 edits and had an account for at least four days, you will have the option to create articles yourself without posting a request to Articles for creation.
Next steps
- Find other Wikipedia articles related to your topic and add links pointing to the new article. This helps readers find it.
- Group the article with similar subjects by adding relevant categories.
- You may consider nominating a fact from the article within the next 7 days to appear on the Main Page's Did you know section.
- Wikipedia is a work in progress. You can continue to expand and improve the new article.
- The new article will become eligible to be indexed on search engines once patrolled or after 90 days; search engines may take time to reflect this.
- For friendly peer support regarding editing, sourcing, or policies, visit the Teahouse, a question and answer hub for new editors.
Thanks again, and happy editing!
Sulfurboy (talk) 19:21, 16 August 2026 (UTC)Welcome, Oeryc!
[edit]
Welcome to Wikipedia, Oeryc! I'm User:The person who loves reading, and I've been assigned as your mentor. All new Wikipedia accounts receive a mentor chosen randomly from a list of volunteers. It just means I'm here to help with anything you need! We need to have all kinds of people working together to create an online encyclopedia, so I'm glad you're here. Over time, you will figure out what you enjoy doing the most on Wikipedia.
You might have noticed that you have access to a tutorial and suggested edits. It's recommended that you take advantage of this, as it'll make learning how to edit Wikipedia easier.
If you need assistance with anything or have any questions, click on the "Get editing help" button on the bottom right corner of your screen. This will open up a module with links to help pages and a place to ask me questions. You can also ask me questions directly on my talk page, or go here to get help from the wider community.
Again, welcome to Wikipedia! The person who loves reading (talk) 23:10, 17 August 2026 (UTC)
Your submission at Articles for creation: Vicadrostat has been accepted
[edit]
Congratulations, and thank you for helping expand the scope of Wikipedia! We hope you will continue making quality contributions. Feel free to further improve your accepted article.
Future articles
- Since you have made at least 10 edits over more than four days, you can now create articles yourself without submitting a draft for review. However, you may continue submitting drafts to Articles for creation if you prefer.
- Once you have made at least 10 edits and had an account for at least four days, you will have the option to create articles yourself without posting a request to Articles for creation.
Next steps
- Find other Wikipedia articles related to your topic and add links pointing to the new article. This helps readers find it.
- Group the article with similar subjects by adding relevant categories.
- You may consider nominating a fact from the article within the next 7 days to appear on the Main Page's Did you know section.
- Wikipedia is a work in progress. You can continue to expand and improve the new article.
- The new article will become eligible to be indexed on search engines once patrolled or after 90 days; search engines may take time to reflect this.
- For friendly peer support regarding editing, sourcing, or policies, visit the Teahouse, a question and answer hub for new editors.
Thanks again, and happy editing!
Shocksingularity (talk) 03:02, 19 August 2026 (UTC)Your submission at Articles for creation: Hemi-flyscaline has been accepted
[edit]
Congratulations, and thank you for helping expand the scope of Wikipedia! We hope you will continue making quality contributions. Feel free to further improve your accepted article.
Future articles
- Since you have made at least 10 edits over more than four days, you can now create articles yourself without submitting a draft for review. However, you may continue submitting drafts to Articles for creation if you prefer.
- Once you have made at least 10 edits and had an account for at least four days, you will have the option to create articles yourself without posting a request to Articles for creation.
Next steps
- Find other Wikipedia articles related to your topic and add links pointing to the new article. This helps readers find it.
- Group the article with similar subjects by adding relevant categories.
- You may consider nominating a fact from the article within the next 7 days to appear on the Main Page's Did you know section.
- Wikipedia is a work in progress. You can continue to expand and improve the new article.
- The new article will become eligible to be indexed on search engines once patrolled or after 90 days; search engines may take time to reflect this.
- For friendly peer support regarding editing, sourcing, or policies, visit the Teahouse, a question and answer hub for new editors.
Thanks again, and happy editing!
Graeme Bartlett (talk) 22:06, 20 August 2026 (UTC)
Hello, I'm Qwerfjkl (bot). I have automatically detected that this edit performed by you, on the page 2C-T-14, may have introduced referencing errors. They are as follows:
- A bare URL and missing title error. References show this error when they do not have a title. Please edit the article to add the appropriate title parameter to the reference. (Fix | Ask for help). Below are the references causing this error:
- isomerdesign.com https://isomerdesign.com/pihkal/read/pk/46#2082. Retrieved 2026-09-05.
{{cite web}}: Missing or empty|title=(help) - isomerdesign.com https://isomerdesign.com/pihkal/read/pk/12#2082. Retrieved 2026-09-05.
{{cite web}}: Missing or empty|title=(help)
- isomerdesign.com https://isomerdesign.com/pihkal/read/pk/46#2082. Retrieved 2026-09-05.
Please check this page and fix the errors highlighted. If you think this is a false positive, you can report it to my operator. Thanks, Qwerfjkl (bot) (talk) 18:27, 5 September 2026 (UTC)
N-Benzylphenethylamines moved to draftspace
[edit]Thanks for your contributions to N-Benzylphenethylamines. Unfortunately, I do not think it is ready for publishing as a live article at this time because it has no sources. I have converted it to a draft which you can improve, undisturbed for a while.
Please see more information at Help:Unreviewed new page. When the article is ready for publication, please click on the "Submit the draft for review!" button at the top of the page OR move the page back. John B123 (talk) 21:33, 9 September 2026 (UTC)
Disambiguation link notification for September 10
[edit]Hi. Thank you for your recent edits. An automated process has detected that when you recently edited GAMMA (drug), a link pointing to the disambiguation page Oral was added. Such links are usually incorrect, since a disambiguation page is merely a list of unrelated topics with similar titles. (Read the FAQ • Join us at the DPL WikiProject.)
It's OK to remove this message. Also, to stop receiving these messages, follow these opt-out instructions. Thanks, --DPL bot (talk) 17:59, 10 September 2026 (UTC)
I have sent you a note about a page you started
[edit]Hi Oeryc. Thank you for your work on 2C-T-14. Another editor, Klbrain, has reviewed it as part of new pages patrol and left the following comment:
Rather borderline notability, given that it's entirely dependent on Shuglin. A merge or redirect to 2C (psychedelics)#List of 2C drugs, where it is tabulated, might be a better solution unless more can be found to expand the article.
To reply, leave a comment here and begin it with {{Re|Klbrain}}. (Message delivered via the Page Curation tool, on behalf of the reviewer.)
I have sent you a note about a page you started
[edit]Hi Oeryc. Thank you for your work on Di-β-phenylisopropylamine. Another editor, Klbrain, has reviewed it as part of new pages patrol and left the following comment:
Thanks for this very interesting, focussed article on a drug sometimes confused with amphetamine. It is clearly structured and appropriately referenced. It's from a large class of compounds, but has sufficient notability for separate coverage.
To reply, leave a comment here and begin it with {{Re|Klbrain}}. (Message delivered via the Page Curation tool, on behalf of the reviewer.)
Trihydroxyphenethylamine moved to draftspace
[edit]An article you recently created, Trihydroxyphenethylamine, is not suitable as written to remain published. It needs more citations from reliable, independent sources. (?) Information that can't be referenced should be removed (verifiability is of central importance on Wikipedia). I've moved your draft to draftspace (with a prefix of "Draft:" before the article title) where you can incubate the article with minimal disruption. When you feel the article meets Wikipedia's general notability guideline and thus is ready for mainspace, please click on the "Submit your draft for review!" button at the top of the page. Dan arndt (talk) 03:12, 22 September 2026 (UTC)
List of Amanita species known to contain psychoactive compounds moved to draftspace
[edit]Thanks for your contributions to List of Amanita species known to contain psychoactive compounds. Unfortunately, I do not think it is ready for publishing as a live article at this time because it has no sources. I have converted it to a draft which you can improve, undisturbed for a while.
Please see more information at Help:Unreviewed new page. When the article is ready for publication, please click on the "Submit the draft for review!" button at the top of the page OR move the page back. -MPGuy2824 (talk) 06:16, 3 October 2026 (UTC)
New cross-language page link: Tetramethoxyallylbenzene
[edit]A new page 6-甲氧基榄香素 on the Chinese Wikipedia has been linked to the page Tetramethoxyallylbenzene, which you created, via Wikidata (Q27138694).
You will not be notified about future links to pages you created. To opt in to these notifications, follow the opt-in instructions.
I have sent you a note about a page you started
[edit]Hi Oeryc. Thank you for your work on Meta-Hydroxyephedrine. Another editor, Klbrain, has reviewed it as part of new pages patrol and left the following comment:
Thanks for creating this page for a compound with a rather long history. It is part of a large class of compounds with similar action. It is well integrated into the family of monoamine reuptake inhibitors. From here, it would be helpful to add further sources, initially to confirm its notability, and then to build content.
To reply, leave a comment here and begin it with {{Re|Klbrain}}. (Message delivered via the Page Curation tool, on behalf of the reviewer.)
I have sent you a note about a page you started
[edit]Hi Oeryc. Thank you for your work on 4-Bromo-α-pyrrolidinopentiophenone. Another editor, Klbrain, has reviewed it as part of new pages patrol and left the following comment:
Thanks for creating this article on a substituted cathinone. There is an argument for consolidating the set of compounds, given that there are so many of them with similar pharmacology. However, it seems reasonable for now to keep this article. Linking it from other articles would be helpful, and that might be most easily done by adding it to the monoamine reuptake inhibitors template.
To reply, leave a comment here and begin it with {{Re|Klbrain}}. (Message delivered via the Page Curation tool, on behalf of the reviewer.)
I have sent you a note about a page you started
[edit]Hi Oeryc. Thank you for your work on Calycanthine. Another editor, Klbrain, has reviewed it as part of new pages patrol and left the following comment:
What a great article; thanks for creating it. While it's no longer an orphan, it might be helpful to link it from a few other places.
To reply, leave a comment here and begin it with {{Re|Klbrain}}. (Message delivered via the Page Curation tool, on behalf of the reviewer.)
I have sent you a note about a page you started
[edit]Hi Oeryc. Thank you for your work on RTI-6037-13. Another editor, Klbrain, has reviewed it as part of new pages patrol and left the following comment:
Thank you for creating this article on a chemical compound. It seems reasonable to keep for now, although I wonder whether a collective page for cathinones with similar properties might be better in the long term in order to avoid overlap. It would also be helpful to source this article from authors other than Carroll et al., in order to better establish notability.
To reply, leave a comment here and begin it with {{Re|Klbrain}}. (Message delivered via the Page Curation tool, on behalf of the reviewer.)
I have sent you a note about a page you started
[edit]Hi Oeryc. Thank you for your work on 6-Aminodopamine. Another editor, Klbrain, has reviewed it as part of new pages patrol and left the following comment:
Thank you for another interesting article; the comparison to 6-hydroxydopamine was certainly helpful to me (that compound perhaps being better know in my corner of pharmacology). Clear and appropriately referenced.
To reply, leave a comment here and begin it with {{Re|Klbrain}}. (Message delivered via the Page Curation tool, on behalf of the reviewer.)
Thanks for your contributions to PAV-0056. Unfortunately, I do not think it is ready for publishing as a live article at this time because it needs more sources to establish notability. I have converted it to a draft which you can improve, undisturbed for a while.
Please see more information at Help:Unreviewed new page. When the article is ready for publication, please click on the "Submit the draft for review!" button at the top of the page OR move the page back. Klbrain (talk) 10:56, 18 October 2026 (UTC)
Tools for chemistry articles
[edit]Hi UseR:Oeryc,
I notice you've been creating a lot of chemistry articles, both individual chemicals and classes or groups. Are you using any tools to help with formatting or content organization, or to help decide what links to add? DMacks (talk) 12:53, 25 October 2026 (UTC)
November 2026
[edit]
Your edit to Amaryllidaceae alkaloid has been removed in whole or in part because it contained copyrighted material without a compatible license. If you are the copyright holder, please follow the process at Wikipedia:Donating copyrighted materials to release your work under compatible licenses. For legal reasons, Wikipedia cannot host copyrighted text or images without a verified compatible license, and all copyright violations will be removed. You may use external websites or publications as a source of information, but you must write using your own words. Limited copying with context is allowed, but requires special care. Wikipedia takes copyright very seriously, and persistent violators of our copyright policy will be blocked from editing. — Diannaa 🍁 (talk) 21:22, 8 November 2026 (UTC)
Hello, I'm Suðurhafsljósæta. An edit that you recently made to Propallorphan seemed to be generated using a large language model (an "AI chatbot" or other application using such technology). Text produced by these applications is not allowed on Wikipedia, and may contain factually inaccurate statements, fictitious citations, or other problems. You should instead read reliable sources and then summarize those in your own words. Your edit may have been reverted. If you want to practice editing, please use your sandbox. If you think a mistake was made, or if you have any questions, you can leave me a message on my talk page, or ask your questions at the Teahouse, a friendly place for new users. Thanks. Suðurhafsljósæta (talk) 12:57, 16 November 2026 (UTC)
ArbCom 2026 Elections voter message
[edit]Hello! Voting in the 2026 Arbitration Committee elections is now open until 23:59 (UTC) on Monday, 30 November 2026. All eligible users are allowed to vote. Users with alternate accounts may only vote once.
The Arbitration Committee is the panel of editors responsible for conducting the Wikipedia arbitration process. It has the authority to impose binding solutions to disputes between editors, primarily for serious conduct disputes the community has been unable to resolve. This includes the authority to impose site bans, topic bans, editing restrictions, and other measures needed to maintain our editing environment. The arbitration policy describes the Committee's roles and responsibilities in greater detail.
If you wish to participate in the 2026 election, please review the candidates and submit your choices on the voting page. If you no longer wish to receive these messages, you may add {{NoACEMM}} to your user talk page. MediaWiki message delivery (talk) 00:41, 17 November 2026 (UTC)